Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Webinar on Advances in Lung Cancer Surgery, with Dr. David Harpole
Author
Howard (Jack) West, MD

GRACE in partnership with LUNGevity Foundation are thrilled to offer our next webinar on Wednesday, October 24th, at 6:30 PM Eastern/3:30 PM Pacific, with the renowned Dr. David Harpole, Thoracic Surgeon and Professor of Surgery at Duke University Medical Center. Dr. Harpole is a great leader in the field of lung surgery who is also a great collaborator with other specialists in lung cancer who thinks a lot about molecular testing and other advances. He'll join us to speak about advances in lung cancer surgery over the past few years and evolving standards.

The program will include his presentation for about 45 minutes, followed by a question and answer session with our live audience.  Registration is free, and through this link.  

We'll turn the program into a series of podcasts that will be available here, on the LUNGevity website, and through iTunes and YouTube, but we hope you'll join us and participate in the live program on Wednesday, October 24th.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora